Seasonal Influenza Epidemiology Forecast 2025-2034

Seasonal Influenza Epidemiology Forecast Report Coverage

Expert Market Research's “Seasonal Influenza Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of seasonal influenza. It projects the future incidence and prevalence rates of seasonal influenza across various populations. The study covers age, gender, and type as major determinants of the seasonal influenza-affected population. The report highlights patterns in the prevalence of seasonal influenza over time and projects future trends based on multiple variables.

Seasonal Influenza Disease Overview

Seasonal influenza is caused by influenza viruses (types A, B, C, and D, with A and B being the most prevalent in humans). It can cause symptoms like fever, cough, sore throat, muscle aches, and exhaustion and is spread by respiratory droplets. High-risk populations, including young children, the elderly, and people with compromised immune systems, are more susceptible to the flu. Globally, outbreaks happen every year, with peak seasons varying based on location and causing substantial healthcare costs.

Seasonal Influenza: Treatment Overview

The goal of treating seasonal influenza is to reduce symptoms and avoid complications, particularly in high-risk patients. If taken early, antiviral drugs such as oseltamivir and zanamivir can help in reducing the severity and length of illness. Treatment also includes supportive care including rest, taking plenty of fluids, along with taking over-the-counter drugs for fever and other painkillers. Hospitalization and additional medical support may be necessary in cases of severe complications.

Epidemiology

The seasonal influenza epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for seasonal influenza by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for seasonal influenza and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• Annually, between 290 000 and 650 000 respiratory deaths are attributed to seasonal influenza across the globe. In developing nations, influenza-related lower respiratory tract infections account for 99% of deaths in children under the age of five.
• Studies indicate that up to 20% of the population is thought to get affected by seasonal influenza every year. As per the estimates, influenza causes 13.8 deaths per 100,000 people annually.
• Another study revealed that most seasonal influenza-related deaths in developed nations occur in people aged 65 and older.
• A study conducted also revealed that for seasonal influenza the incubation period, or the time between infection and illness, is roughly 2 days, though it can vary from 1-4 days.

Country-wise Seasonal Influenza Epidemiology

The seasonal influenza epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of seasonal influenza varies between countries owing to the differences in factors such as obesity, tobacco smoking, diabetes and others. According to the Global Change Data Lab, flu causes about 31 respiratory deaths per 100,000 people over 65 each year in Europe. Around 400,000 people worldwide are thought to die from respiratory illnesses and 300,000 from cardiovascular diseases due to seasonal influenza.

Country Specific Stats:

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of seasonal influenza based on several factors.
• Seasonal Influenza Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of seasonal influenza are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of seasonal influenza epidemiology in the 8 major markets?
• What will be the total number of patients with seasonal influenza across the 8 major markets during the forecast period?
• What was the country-wise prevalence of seasonal influenza in the 8 major markets in the historical period?
• Which country will have the highest number of seasonal influenza patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of seasonal influenza during the forecast period of 2025-2034?
• What are the currently available treatments for seasonal influenza?
• What are the disease risks, signs, symptoms, and unmet needs of seasonal influenza?

Related Reports

Global Influenza Vaccine Market

Global Influenza Diagnostics Market